Macrogenics (MGNX) Accumulated Expenses (2012 - 2026)

Macrogenics (MGNX) has 15 years of Accumulated Expenses data on file, last reported at $18.4 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 33.74% year-over-year to $18.4 million in Q1 2026; TTM through Mar 2026 was $18.4 million, a 33.74% decrease from a year earlier, with the FY2025 full-year figure at $22.2 million, down 24.22% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $18.4 million, down from $22.2 million in the prior quarter.
• Over the last five years, Accumulated Expenses for MGNX reached as high as $33.3 million in Q3 2022 and fell as low as $18.1 million in Q1 2024.
• Historically, Accumulated Expenses has averaged $26.0 million across 5 years, with a median of $25.5 million in 2023.
• Across the five-year window, Accumulated Expenses slumped 35.62% in 2024 and soared 53.39% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $29.0 million in 2022, then fell by 16.41% to $24.2 million in 2023, then grew by 21.02% to $29.3 million in 2024, then decreased by 24.22% to $22.2 million in 2025, then decreased by 17.02% to $18.4 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $18.4 million in Q1 2026, $22.2 million in Q4 2025, and $23.1 million in Q3 2025.